These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 17050805

  • 21. Radiosensitizing and toxic properties of quinoline and nitroquinoline complexes of platinum [PtCl2(NH3)quinoline].
    Skov KA, Adomat H, Doedee M, Farrell N.
    Anticancer Drug Des; 1994 Apr; 9(2):103-17. PubMed ID: 8166927
    [Abstract] [Full Text] [Related]

  • 22. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J, Liebeke M, Kaiser M, Bracht K, Olszewski U, Zeillinger R, Hamilton G, Braun D, Bednarski PJ.
    Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
    [Abstract] [Full Text] [Related]

  • 23. Cytotoxic activity and chemical reactivity of cis-platinum(II) and trans-palladium(II) complexes with diethyl (pyridinylmethyl)phosphates.
    Kalinowska-Lis U, Szmigiero L, Studzian K, Ochocki J.
    Eur J Med Chem; 2009 Feb; 44(2):660-4. PubMed ID: 18586354
    [Abstract] [Full Text] [Related]

  • 24. Mutagenicity, tumorigenicity, and electrophilic reactivity of the stereoisomeric platinum(II) complexes of 1,2-diaminocyclohexane.
    Leopold WR, Batzinger RP, Miller EC, Miller JA, Earhart RH.
    Cancer Res; 1981 Nov; 41(11 Pt 1):4368-77. PubMed ID: 7030475
    [Abstract] [Full Text] [Related]

  • 25. DNA interactions of new antitumor platinum complexes with trans geometry activated by a 2-metylbutylamine or sec-butylamine ligand.
    Prokop R, Kasparkova J, Novakova O, Marini V, Pizarro AM, Navarro-Ranninger C, Brabec V.
    Biochem Pharmacol; 2004 Mar 15; 67(6):1097-109. PubMed ID: 15006546
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Synthesis, characterization and cytotoxicity evaluation of some new platinum(II) complexes of tetrazolo[1,5-a]quinolines.
    Bekhit AA, El-Sayed OA, Al-Allaf TA, Aboul-Enein HY, Kunhi M, Pulicat SM, Al-Hussain K, Al-Khodairy F, Arif J.
    Eur J Med Chem; 2004 Jun 15; 39(6):499-505. PubMed ID: 15183908
    [Abstract] [Full Text] [Related]

  • 31. Synthesis of 1-(2-aminophenyl)isoquinolines and the biological activity of their cis-dichloro platinum(II) complexes.
    von Nussbaum F, Miller B, Wild S, Hilger CS, Schumann S, Zorbas H, Beck W, Steglich W.
    J Med Chem; 1999 Sep 09; 42(18):3478-85. PubMed ID: 10479280
    [Abstract] [Full Text] [Related]

  • 32. Antitumor effect of Pt(II) amine phosphonate complexes on sarcoma sa-180 in mice. Crystal structure of cis-dichlorobis(diethyl-4-pyridylmethylphosphonate-kappaN)platinum(II) hydrate, cis-[PtCl2(4-pmpe)2].H20.
    Aranowska K, Graczyk J, Checińska L, Pakulska W, Ochock J.
    Pharmazie; 2006 May 09; 61(5):457-60. PubMed ID: 16724546
    [Abstract] [Full Text] [Related]

  • 33. Studies of interaction of trichloro{eta2-cis-N,N-dimethyl-1-[6-(N',N'-dimethyl-ammoniummethyl)-cyclohex-3-ene-1-yl]-methylammonium}platinum(II) chloride with DNA: Effects on secondary and tertiary structures of DNA. Cytotoxic assays on human ovarian cancer cell lines, resistant and non-resistant to cisplatin.
    Gay M, Montaña AM, Moreno V, Prieto MJ, Pérez JM, Alonso C.
    Bioorg Med Chem; 2006 Mar 01; 14(5):1565-72. PubMed ID: 16256352
    [Abstract] [Full Text] [Related]

  • 34. Cytotoxicity and DNA binding mode of new platinum-iminoether derivatives with different configuration at the iminoether ligands.
    Boccarelli A, Coluccia M, Intini FP, Natile G, Locker D, Leng M.
    Anticancer Drug Des; 1999 Jun 01; 14(3):253-64. PubMed ID: 10500500
    [Abstract] [Full Text] [Related]

  • 35. Chiral platinum(II) metallointercalators with potent in vitro cytotoxic activity.
    Fisher DM, Bednarski PJ, Grünert R, Turner P, Fenton RR, Aldrich-Wright JR.
    ChemMedChem; 2007 Apr 01; 2(4):488-95. PubMed ID: 17340669
    [Abstract] [Full Text] [Related]

  • 36. Influence of amine ligands on the aquation and cytotoxicity of trans-diamine platinum(II) anticancer complexes.
    Cubo L, Quiroga AG, Zhang J, Thomas DS, Carnero A, Navarro-Ranninger C, Berners-Price SJ.
    Dalton Trans; 2009 May 14; (18):3457-66. PubMed ID: 19381408
    [Abstract] [Full Text] [Related]

  • 37. Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand.
    Kasparkova J, Vojtiskova M, Natile G, Brabec V.
    Chemistry; 2008 May 14; 14(4):1330-41. PubMed ID: 18022972
    [Abstract] [Full Text] [Related]

  • 38. Effects of a piperidine ligand on DNA modification by antitumor cisplatin analogues.
    Kasparkova J, Novakova O, Najajreh Y, Gibson D, Perez JM, Brabec V.
    Chem Res Toxicol; 2003 Nov 14; 16(11):1424-32. PubMed ID: 14615968
    [Abstract] [Full Text] [Related]

  • 39. The role of p53 in the cellular toxicity by active trans-platinum complexes containing isopropylamine and hydroxymethylpyridine.
    Ramos-Lima FJ, Moneo V, Quiroga AG, Carnero A, Navarro-Ranninger C.
    Eur J Med Chem; 2010 Jan 14; 45(1):134-41. PubMed ID: 19853978
    [Abstract] [Full Text] [Related]

  • 40. Antiproliferative activity of some cis-/trans-platinum(II) complexes on HeLa cells.
    Arandjelovic S, Tesic Z, Juranic Z, Radulovic S, Vrvic M, Potkonjak B, Ilic Z.
    J Exp Clin Cancer Res; 2002 Dec 14; 21(4):519-26. PubMed ID: 12636098
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.